PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|15|30|3464-3475

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.30, 2009-10, pp. : 3464-3475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE5 Inhibitors and their Applications

By  

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Modulation of Cytotoxicity and Cellular Uptake of Anti-cancer Drugs by PDE5 Inhibitors in Lung Cancer Cells

By Li Qing   Shu Yan  

Pharmaceutical Research, Vol. 31, Iss. 1, 2014-01 ,pp. : 86-96

Springer Publishing Company

Access to resources Recommend Favorite

PDE-5 Inhibitors: Clinical Points

By  

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors in the Treatment of LUTS

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3502-3505

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological profile of a novel series of NK 1 antagonists. In vitro and in vivo potency of benzimidazolone derivatives

By Remond G.   Portevin B.   Bonnet J.   Canet E.   Regoli D.   De Nanteuil G.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 11, 1997-11 ,pp. : 843-868

Elsevier

Access to resources Recommend Favorite